Physician profile
Cheryl Kellogg
NPI 1376561027
$1,684.29
in general payments reported to CMS, 2019-2025
10 companies · $252 in 2025
The $252 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65.58 · 2020: $285 · 2021: $528 · 2022: $203 · 2023: $74.94 · 2024: $276 · 2025: $252.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $603.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $603.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,291.56 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $128.14 | 2020-2021 | |
| Exact Sciences Corporation | $49.58 | 2025 | Cologuard Collection Kit |
| Allergan, INC. | $44.64 | 2020 | |
| Amgen INC. | $44.58 | 2021 | |
| Glaxosmithkline, LLC. | $42.60 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $42.34 | 2021 | |
| Idorsia Pharmaceuticals US INC | $14.96 | 2023 | Quviviq |
| Currax Pharmaceuticals LLC | $13.35 | 2023 | Contrave |
| Ironwood Pharmaceuticals, INC | $12.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheryl Kellogg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.